LORI HALDEMAN: Open Payments
NPI 1386872380 · SALEM, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 105 payments from 13 companies in 2025. Trend: 2023 $1,161 · 2024 $1,839 · 2025 $2,026
Food & beverage: $2,026
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $964 |
| PFIZER INC. | 10 | $195 |
| Exact Sciences Corporation | 10 | $185 |
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| Novo Nordisk Inc | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 1 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Amgen Inc. | 3 | $51 |
Products named: QULIPTA, VRAYLAR, UBRELVY, Cologuard Collection Kit, NURTEC ODT, FARXIGA, CAPLYTA, AIRSUPRA.
Industry payments across WV — which companies pay providers there.
